Research that Identifies
Undiscovered Value in the MicroCap Market

Global WholeHealth Partners Corp.

Global WholeHealth Partners Email Alerts: Click to Subscribe

View Company Website: Click to View

Market Data: Yahoo Finance, Bloomberg, SEC

Report Link: Final Research Report (Dated 03/1/2021)

Symbol: GWHP
Analyst: Howard Halpern
Taglich Rating: Suspended
Price Target: NA
Time Horizon: NA
Rating Established: May 1, 2021
Price When Established: $0.81
Most Recent Report: May 1, 2021
Price When Issued: $0.81

What's New

New information will be posted soon...

Company Description

Global WholeHealth Partners Corp., headquartered in San Clemente, CA, was founded to develop, manufacture and market in-vitro and rapid diagnostic tests. The company’s vision is to provide infectious disease diagnostics and molecular solutions that reduce the time to diagnose medical results. The company plans to produce and sell rapid diagnostic tests that include but is not limited to, Corona Viruses including COVID-19, Ebola, ZIKA, Dengue, Malaria, Influenza, and Tuberculosis.

Company Reports

Final Research Report (Dated May 1, 2021)

Updated Research Report (Dated December 1, 2020)

Initial Research Report (Dated October 15, 2020)


Please view our current disclosure and disclaimer on our most recent research report.